caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578661583

Gary Cushing

PRACTICELAHEY CLINIC HOSPITAL INCSee all providers at this practice →
Internal MedicineBurlington, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Gary Cushing's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 38 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
POLLAK, ALAIN2756
Lisl Warren
Diagnostic Radiology · Burlington, MA
2443
Anita Uppin
Diagnostic Radiology · Burlington, MA
2340
Dmitry Elentuck
Diagnostic Radiology · Burlington, MA
2352
Mary Beth Hodge
Endocrinology · Burlington, MA
2298
Edward Walshe
Nephrology · Burlington, MA
21133
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
2138
Christoph Wald
Diagnostic Radiology · Rochester, MN
2144
MORRIS, PATRICIA2046
MIRBACH, BRUCE2067
Angela Restrepo
Endocrinology · Burlington, MA
1964
NPI 12757974821949
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
870
Beneficiaries
—
Total drug cost
$277K
Distinct drugs
22
Brand share
47.5%
Top prescribed drugs
Levothyroxine Sodium192 claims
Empagliflozin78 claims
Metformin Hcl72 claims
Dulaglutide44 claims
Insulin Glargine,hum.Rec.Anlog35 claims
QUALITY · MIPS · 2024
Final MIPS score
92.0
Quality
76.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.